Latest Financial Position News

Corporate Travel Management Limited has delayed its FY25 financial results due to potential revenue recognition adjustments in Europe, prompting a voluntary ASX trading suspension.

Integrated Research reported steady pro-forma revenue in FY25 despite declines in statutory revenue and profits, driven by a softer renewals book and market uncertainty. The company’s product-led growth strategy gained momentum with new product launches and a major contract renewal.

Imugene Limited reported a significant 54% reduction in net loss for FY25, driven by cost efficiencies and promising clinical progress in its immuno-oncology pipeline. The company’s lead asset, azer-cel, achieved a 79% response rate in Phase 1b trials and secured FDA Fast Track designation.

Peninsula Energy has successfully completed the first tranche of a fully underwritten A$69.9 million equity raise, securing strong institutional support including cornerstone investors Tees River and Davidson Kempner. The company now opens its retail entitlement offer to shareholders, aiming to fund the ramp-up of uranium production at its Lance Project in Wyoming.

Propel Funeral Partners has reported record FY25 results, exceeding revenue and EBITDA guidance while maintaining steady dividends and announcing a key executive transition.

Propel Funeral Partners reported a solid 14.5% increase in statutory profit for FY25, driven by strategic acquisitions despite a slowdown in death volumes. The company also declared a fully franked final dividend of 7.0 cents per share.

Chrysos Corporation reported a robust 46% revenue increase to A$66.1 million for FY25 but faced a significant net loss of A$8.2 million, reflecting rising costs and operational challenges.

Corporate Travel Management Limited has requested a voluntary suspension of its shares on the ASX as it navigates unresolved issues with its FY25 financial statements, delaying their release until late September.

Big River Industries reported a 2.3% revenue decline for FY25 amid tough market conditions but achieved a notable rebound in the second half, driven by operational efficiencies and cost controls. The company maintains a strong balance sheet and a cautiously optimistic outlook for FY26.

Centrepoint Alliance has reported a robust FY25 with 13% revenue growth and a 30% increase in profit before tax, driven by organic adviser expansion, strategic acquisitions, and pioneering technology investments including AI and cybersecurity.

Austco Healthcare Limited reported a record $81.4 million in revenue for FY25, driven by organic growth and acquisitions including G&S Technologies. EBITDA jumped 62% to $13 million, reflecting strong operational leverage.

Kelsian Group Limited has announced a fully franked ordinary dividend of AUD 0.095 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a choice to reinvest.